McCracken Joseph S
Insider CIK 1632454 · (LUMO) Director · SVRA Director · KIN Director · NVET Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SVRA Savara Inc | M Exercise deriv | 2026-02-16 | 2026-02-17 | 1,807 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2026-02-16 | 2026-02-17 | 1,807 | $1.76 | $3.2K | 302,644 | SEC↗ |
| SVRA Savara Inc | A Award | 2025-12-09 | 2025-12-11 | 40,000 | — | $0 | 300,837 | SEC↗ |
| SVRA Savara Inc | P Buy | 2025-05-29 | 2025-06-02 | 10,000 | $2.08 | $20.8K | 260,837 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,910 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,431 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 5,684 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,328 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 3,345 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer | 2024-12-12 | 2024-12-13 | 15,721 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | A Award | 2024-12-12 | 2024-12-16 | 40,000 | — | $0 | 250,837 | SEC↗ |
| SVRA Savara Inc | P Buy | 2024-11-19 | 2024-11-20 | 20,000 | $2.95 | $59.0K | 210,837 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2024-06-05 | 2024-06-07 | 3,328 | — | $0 | 3,328 | SEC↗ |
| SVRA Savara Inc | A Award | 2023-12-14 | 2023-12-15 | 22,500 | — | $0 | 190,837 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2023-05-10 | 2023-05-12 | 3,345 | — | $0 | 3,345 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2022-12-13 | 2022-12-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | P Buy | 2022-11-16 | 2022-11-18 | 4,000 | $5.03 | $20.1K | 15,721 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | P Buy | 2022-08-25 | 2022-08-26 | 3,170 | $8.60 | $27.3K | 11,721 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2022-05-05 | 2022-05-09 | 3,431 | — | $0 | 3,431 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2021-12-14 | 2021-12-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KIN Kindred Biosciences, Inc. | D To issuer deriv | 2021-08-27 | 2021-08-30 | 41,890 | — | $0 | 0 | SEC↗ |
| KIN Kindred Biosciences, Inc. | D To issuer deriv | 2021-08-27 | 2021-08-30 | 48,500 | — | $0 | 0 | SEC↗ |
| KIN Kindred Biosciences, Inc. | D To issuer deriv | 2021-08-27 | 2021-08-30 | 48,500 | — | $0 | 0 | SEC↗ |
| KIN Kindred Biosciences, Inc. | D To issuer deriv | 2021-08-27 | 2021-08-30 | 48,500 | $4.81 | $233.3K | 0 | SEC↗ |
| KIN Kindred Biosciences, Inc. | D To issuer deriv | 2021-08-27 | 2021-08-30 | 10,000 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | P Buy | 2021-08-11 | 2021-08-13 | 7,475 | $7.55 | $56.4K | 8,551 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2021-05-20 | 2021-05-24 | 2,910 | — | $0 | 2,910 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2021-05-20 | 2021-05-24 | 367 | — | $0 | 1,076 | SEC↗ |
| SVRA Savara Inc | P Buy | 2021-03-15 | 2021-03-15 | 68,965 | $1.45 | $100.0K | 168,337 | SEC↗ |
| KIN Kindred Biosciences, Inc. | A Award deriv | 2021-01-20 | 2021-01-22 | 48,500 | — | $0 | 48,500 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2020-12-16 | 2020-12-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2020-04-03 | 2020-04-07 | 5,684 | — | $0 | 5,684 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2020-04-03 | 2020-04-07 | 709 | — | $0 | 709 | SEC↗ |
| KIN Kindred Biosciences, Inc. | A Award deriv | 2020-01-17 | 2020-01-22 | 48,500 | — | $0 | 48,500 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2019-12-20 | 2019-12-26 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2019-07-05 | 2019-07-08 | 9,034 | — | $0 | 1,807 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2019-07-05 | 2019-07-08 | 21,682 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2019-07-05 | 2019-07-08 | 2,930 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2019-07-05 | 2019-07-08 | 5,860 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2019-07-05 | 2019-07-08 | 2,930 | $0.82 | $2.4K | 84,478 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2019-07-05 | 2019-07-08 | 5,860 | $1.46 | $8.6K | 90,338 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2019-07-05 | 2019-07-08 | 9,034 | $1.76 | $15.9K | 99,372 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2019-07-05 | 2019-07-08 | 21,682 | $0.82 | $17.8K | 81,548 | SEC↗ |
| KIN Kindred Biosciences, Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 48,500 | — | $0 | 48,500 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2018-12-13 | 2018-12-14 | 12,000 | — | $0 | 12,000 | SEC↗ |
| KIN Kindred Biosciences, Inc. | A Award deriv | 2018-06-22 | 2018-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KIN Kindred Biosciences, Inc. | A Award deriv | 2018-04-20 | 2018-04-24 | 41,890 | — | $0 | 41,890 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2017-12-17 | 2017-12-19 | 3,750 | — | $0 | 3,750 | SEC↗ |
| NVET Nexvet Biopharma plc | D To issuer | 2017-07-31 | 2017-08-02 | 16,400 | $6.72 | $110.2K | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2017-07-01 | 2017-07-05 | 3,600 | — | $0 | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2017-07-01 | 2017-07-05 | 3,600 | $0.13 | $468 | 16,400 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2017-06-30 | 2017-07-05 | 500 | — | $0 | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2017-06-30 | 2017-07-05 | 500 | $0.13 | $65 | 12,800 | SEC↗ |
| SVRA Savara Inc | P Buy | 2017-06-07 | 2017-06-09 | 52,250 | $4.75 | $248.2K | 59,866 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2017-03-31 | 2017-04-04 | 500 | — | $0 | 500 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2017-03-31 | 2017-04-04 | 500 | $0.13 | $65 | 12,300 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2016-12-31 | 2017-01-03 | 500 | — | $0 | 1,000 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2016-12-31 | 2017-01-03 | 500 | $0.13 | $65 | 11,800 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2016-09-30 | 2016-10-04 | 500 | — | $0 | 1,500 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2016-09-30 | 2016-10-04 | 500 | $0.13 | $65 | 11,300 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2016-09-05 | 2016-09-07 | 3,600 | — | $0 | 3,600 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2016-07-01 | 2016-07-01 | 3,600 | — | $0 | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2016-07-01 | 2016-07-01 | 3,600 | $0.13 | $468 | 10,800 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2016-06-30 | 2016-07-01 | 500 | — | $0 | 2,000 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2016-06-30 | 2016-07-01 | 500 | $0.13 | $65 | 7,200 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2016-03-31 | 2016-04-04 | 500 | — | $0 | 2,500 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2016-03-31 | 2016-04-04 | 500 | $0.13 | $65 | 6,700 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2015-12-31 | 2016-01-05 | 500 | — | $0 | 3,000 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2015-12-31 | 2016-01-05 | 500 | $0.13 | $65 | 6,200 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2015-09-30 | 2015-10-01 | 500 | — | $0 | 3,500 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2015-09-30 | 2015-10-01 | 500 | $0.13 | $65 | 5,700 | SEC↗ |
| NVET Nexvet Biopharma plc | A Award deriv | 2015-09-03 | 2015-09-08 | 3,600 | — | $0 | 3,600 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2015-06-30 | 2015-07-02 | 500 | — | $0 | 4,000 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2015-06-30 | 2015-07-02 | 900 | — | $0 | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2015-06-30 | 2015-07-02 | 500 | $0.13 | $65 | 5,200 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2015-06-30 | 2015-07-02 | 900 | $0.13 | $117 | 4,700 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2015-05-18 | 2015-05-20 | 500 | — | $0 | 4,500 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2015-05-18 | 2015-05-20 | 900 | — | $0 | 900 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2015-05-18 | 2015-05-20 | 1,400 | $0.13 | $182 | 3,800 | SEC↗ |